HIGHLIGHTS
- who: Etienne Delangre et al. from the Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland have published the research work: S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma, in the Journal: (JOURNAL) of 26/08/2022
- what: NAFLD/NASH and HCC have a high prevalence among the global worldwide population and represent major public health concerns in our society.
- future: Studies are now required to develop neutralizing antibodies against relevant circulating S100 isoforms aberrantly expressed with NAFLD/NASH and liver cancers e_g S100A4 and S100A11 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.